Patent details

Basic Information

Publication number:

EP3706779

PCT Application Number:

US2018058837

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP188158315

PCT Publication Number:

WO2019094268

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS AND METHODS OF USE OF INTERLEUKIN-10 IN COMBINATION WITH IMMUNE CHECKPOINT PATHWAY INHIBITORS

French Title of Invention:

COMPOSITIONS ET PROCÉDÉS D'UTILISATION DE L'INTERLEUKINE-10 EN ASSOCIATION AVEC DES INHIBITEURS DE VOIES DE POINTS DE CONTRÔLE IMMUNITAIRE

German Title of Invention:

ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON INTERLEUKIN-10 IN KOMBINATION MIT INHIBITOREN DES IMMUNCHECKPOINT-SIGNALWEGS

SPC Number:

Dates

Filing date:

02/11/2018

Grant date:

14/12/2022

EP Publication Date:

16/09/2020

PCT Publication Date:

16/05/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/12/2022

EP B1 Publication Date:

14/12/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/11/2023

Expiration date:

12/09/2000

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/12/2022

 

 

Name:

Armo Biosciences, Inc.

Address:

575 Chesapeake Dr., Redwood City, CA 94063, United States (US)

Inventor

Name:

OFT, Martin

Address:

United States (US)

Priority

Priority Number:

201762584610 P

Priority Date:

10/11/2017

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/20; A61K 39/395; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202250

Publication date:

14/12/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages